UK consumers reduced their purchases of food and alcohol during the recent holiday season, with industry experts attributing the trend to the increasing use of weight loss injections. Grocery sales totaled £19.6 billion in the four weeks leading up to December 27, marking a 2.5% increase compared to the previous year, as reported by market research firm NielsenIQ. However, sales volume experienced a slight 0.2% decline.
Analysts in the retail sector suggest that this shift is linked to the growing popularity of GLP-1 injections, which replicate a hormone that induces a sense of fullness in the body. These injections, such as Mounjaro and Wegovy for weight loss and Ozempic for diabetes, are prescribed by the NHS. Recent data from University College London estimates that approximately 1.6 million adults in the UK have utilized these injections within the last year.
Retail expert Jonathan De Mello from JDM Retail noted that the impact of Ozempic is becoming a notable trend in the grocery industry, with a rise in GLP-1 usage correlating with a decline in year-on-year grocery sales volume among users. He highlighted that food categories high in calories, like snacks and alcohol, have been particularly affected. As this pattern gains traction, retailers may need to adjust their product offerings to cater to the shift toward more mindful consumption habits.
Consumer analyst Clive Black of Shore Capital emphasized that the decrease in grocery volume sales during the Christmas period could be directly linked to the influence of GLP drugs on eating behaviors. Major retailers have responded by launching smaller meal options, with Co-op introducing “mini meals” tailored for smaller appetites, Marks & Spencer unveiling a new “nutrient dense” range, and Iceland expanding its frozen ready meal selection with 38 new products.
The impact of weight loss injections on businesses is evident, as Greggs’ CEO acknowledged that the company experienced a shift in consumer preferences, with a focus on smaller portions and nutritional information. Other supermarket executives, such as Tesco’s Ken Murphy and Sainsbury’s Simon Roberts, have stated their awareness of changing consumer trends driven by the rise of weight loss medications.
As consumer habits evolve, retailers are closely monitoring these developments to adapt their offerings accordingly.